Financials Honliv Healthcare Management Group Company Limited
Equities
9906
KYG4594A1040
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 HKD | 0.00% | 0.00% | -5.26% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 1,040 | 1,232 | 1,293 | 1,451 |
Enterprise Value (EV) 1 | 987.9 | 1,157 | 1,181 | 1,392 |
P/E ratio | 41.3 x | 33.6 x | 26.1 x | 36.9 x |
Yield | - | - | - | - |
Capitalization / Revenue | 1.99 x | 2.03 x | 1.78 x | 1.91 x |
EV / Revenue | 1.89 x | 1.91 x | 1.62 x | 1.83 x |
EV / EBITDA | 10.9 x | 12.1 x | 10.1 x | 12.2 x |
EV / FCF | -37.9 x | 76 x | 13.6 x | -109 x |
FCF Yield | -2.64% | 1.32% | 7.33% | -0.92% |
Price to Book | 1.98 x | 2.19 x | 2.35 x | 2.68 x |
Nbr of stocks (in thousands) | 600,000 | 600,000 | 600,000 | 600,000 |
Reference price 2 | 1.734 | 2.053 | 2.155 | 2.418 |
Announcement Date | 21-04-19 | 22-04-22 | 23-04-21 | 24-04-29 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 496.6 | 531.1 | 524 | 606.8 | 727.8 | 760.5 |
EBITDA 1 | 130.8 | 116.3 | 90.6 | 95.73 | 116.9 | 113.9 |
EBIT 1 | 111.2 | 96.52 | 66.58 | 66.62 | 66.03 | 57.46 |
Operating Margin | 22.4% | 18.17% | 12.71% | 10.98% | 9.07% | 7.56% |
Earnings before Tax (EBT) 1 | 98.47 | 68.48 | 30.85 | 50.54 | 63.02 | 51.42 |
Net income 1 | 72.73 | 49.36 | 21.84 | 36.62 | 48.95 | 38.31 |
Net margin | 14.65% | 9.29% | 4.17% | 6.03% | 6.73% | 5.04% |
EPS 2 | 0.1638 | 0.1103 | 0.0420 | 0.0610 | 0.0827 | 0.0656 |
Free Cash Flow 1 | 154.6 | -60.32 | -26.05 | 15.23 | 86.61 | -12.78 |
FCF margin | 31.13% | -11.36% | -4.97% | 2.51% | 11.9% | -1.68% |
FCF Conversion (EBITDA) | 118.2% | - | - | 15.91% | 74.08% | - |
FCF Conversion (Net income) | 212.53% | - | - | 41.59% | 176.95% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 20-06-24 | 20-06-24 | 21-04-19 | 22-04-22 | 23-04-21 | 24-04-29 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 194 | 172 | - | - | - | - |
Net Cash position 1 | - | - | 52.4 | 75.1 | 112 | 59 |
Leverage (Debt/EBITDA) | 1.487 x | 1.478 x | - | - | - | - |
Free Cash Flow 1 | 155 | -60.3 | -26 | 15.2 | 86.6 | -12.8 |
ROE (net income / shareholders' equity) | 53.6% | 28.6% | 5.75% | 6.75% | 8.8% | 7.02% |
ROA (Net income/ Total Assets) | 11.6% | 9.02% | 4.9% | 4.31% | 4.35% | 3.77% |
Assets 1 | 627.7 | 547 | 445.5 | 850.4 | 1,125 | 1,015 |
Book Value Per Share 2 | 0.2300 | 0.5300 | 0.8800 | 0.9400 | 0.9200 | 0.9000 |
Cash Flow per Share 2 | 0.0200 | 0.2300 | 0.5000 | 0.4400 | 0.4300 | 0.4000 |
Capex 1 | 6.93 | 65.4 | 80.4 | 51 | 18.9 | 89.3 |
Capex / Sales | 1.4% | 12.31% | 15.35% | 8.41% | 2.6% | 11.74% |
Announcement Date | 20-06-24 | 20-06-24 | 21-04-19 | 22-04-22 | 23-04-21 | 24-04-29 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-5.26% | 193M | |
-18.90% | 16.72B | |
+4.50% | 12.64B | |
+4.81% | 11.7B | |
+2.43% | 10B | |
+29.74% | 8.7B | |
-4.75% | 7.6B | |
+21.11% | 7.22B | |
+5.50% | 6.65B | |
+45.72% | 4.5B |
- Stock Market
- Equities
- 9906 Stock
- Financials Honliv Healthcare Management Group Company Limited